SARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268877 | PMC |
| http://dx.doi.org/10.1097/MAT.0000000000001198 | DOI Listing |
Publication Analysis
Top Keywords
extracorporeal membrane
8
membrane oxygenation
8
ecmo support
8
veno-venous extracorporeal
4
oxygenation support
4
covid-19
4
support covid-19
4
covid-19 respiratory
4
respiratory distress
4
distress syndrome
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!